NovoCure Limited 0.0% 01-NOV-2025NovoCure Limited 0.0% 01-NOV-2025NovoCure Limited 0.0% 01-NOV-2025

NovoCure Limited 0.0% 01-NOV-2025

No trades
See on Supercharts

NVCR5301073 analysis



Key facts


Issue date
Nov 10, 2021
Maturity date
Nov 1, 2025
Outstanding amount
‪560.95 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
0% (Zero)
Yield to maturity
5.79%
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.